Novartis kept pay for its Chief Executive Joe Jimenez steady, after cutting it last year before a Swiss vote to force companies to accept shareholder limits on executive rewards. The Basel-based drugmaker, typically the first Swiss blue-chip company pay to disclose pay, said on Wednesday Jimenez was paid 13.2 million Swiss francs ($14.69 million) in total for 2013, more than 3 million francs of it in cash. This year's pay report is the first since Novartis had to scrap a planned 72 million franc payout to outgoing chairman Daniel Vasella three days before facing furious shareholders. Pay for incoming chairman Joerg Reinhardt is far more modest than that of Vasella, who had been a lightning rod for criticism since a $20 million pay package in 2006.
via Health News Headlines - Yahoo News http://ift.tt/1a0XlOG
No comments:
Post a Comment